AGP Executive Report

Regulatory Watch: Eli Lilly’s once-daily weight-loss/diabetes pill Foundayo (orforglipron) hits UK pharmacies today after MHRA authorization, with MHRA warning pharmacists to watch for fake or counterfeit GLP-1 tablets. Women’s Health Access: Aminu Kano Teaching Hospital in Nigeria has started IVF, beginning with egg collection from two women and plans to expand to additional patients. Clinical AI ROI: Cleveland Clinic says ambient scribing helped clinician retention after onboarding 4,000+ ambulatory clinicians in four months, reporting 60% of users more likely to stay in practice. Oncology Trial Design: New CNS metastases guidance argues it’s no longer ethical to exclude patients with brain mets from many early oncology trials, pushing for direct CNS cohorts. Cancer Surgery Tech: University of Pennsylvania researchers discuss VISUALIZE data for fluorescent lung-cancer imaging agent abenacianine (VGT-309) to improve margin and lymph-node detection. Healthcare Business & Policy: FTC/EHR platform scrutiny is framed as a potential antitrust issue tied to data access and competition. Pharma Deal: AstraZeneca pays $600M upfront for global rights to Zegfrovy (sunvozertinib) for EGFR exon 20 NSCLC, with up to $1.5B in milestones. Public Health: Nepal urges Japanese encephalitis prevention as deaths rise; most fatal cases were unvaccinated.

Pharma Industrial Growth: Ghana plans a pharmaceutical industrial park under its 24‑Hour Economy push, aiming to pull in local and international manufacturers and build an end-to-end ecosystem (land, roads, power, water, wastewater) for medicines, devices, R&D, and herbal products. Regulatory & Safety Focus: India’s pharma safety industry group warns companies to move from “compliance-only” to predictive fire-prevention systems, citing risks from complex processes and combustible dust. Clinical & Consumer Health: A trial finds one 75-minute weekly interval-walking session can match the fat-loss effects of three shorter sessions. Another study links higher ultra-processed food intake in early childhood to smaller brain regions tied to emotion and motivation by age 6. Diagnostics & Devices: FDA authorization clears a fully autonomous robotic blood draw device. Public Health Alerts: Delhi issues an H1N1 (swine flu) advisory as cases rise, urging respiratory hygiene and timely care. Food Safety: Federal officials investigate a multistate alfalfa sprout outbreak tied to a Minnesota supplier.

Regulatory Watch: AMO Pharma says regulators in the US, UK, and Canada have aligned on a registrational study design for AMO-02 in congenital myotonic dystrophy type 1, with hospitalization set as the primary endpoint and an update expected in Q3 2026. Oncology & Evidence Use: Clinicians are weighing real-world outcomes and dose-reduction patterns for NALIRIFOX in metastatic pancreatic cancer against NAPOLI-3 trial results. Public Health Alert: FDA and CDC are investigating a multistate alfalfa sprout outbreak tied to Everything Sprouts LLC, with 55 illnesses across 15 states and several hospitalizations. Respiratory Care: A year after FDA approval, pulmonologists are refining brensocatib patient selection for non-cystic fibrosis bronchiectasis, focusing on frequent exacerbators and tolerability. AI in Healthcare Policy: India’s health minister urged a shift from “pharmacy” to “laboratory of the world,” using AI for drug discovery and better access, while stressing human-centered safeguards. Drug Safety & Access: Oregon approved double-digit marketplace health insurance premium hikes for 2027 as regulators cite market changes and uncertainty.

Regulatory Watch: FDA accepted Teva’s ecopipam NDA for pediatric Tourette syndrome and granted priority review, while also flagging other FDA moves in the Tourette/psychiatry pipeline. Healthcare Workforce: UC physicians in California launched a major attending-doctor unionization push, citing rising labor burden, patient boarding problems, and degraded working conditions. Pharma Safety: A reactor blast at a Telangana pharma unit (Hazelo Lab/Hazelo Pharma) killed two workers and injured nine, with authorities investigating the cause after the fire was contained. Industry & Policy: India’s health minister urged a shift from “Pharmacy of the World” to “Laboratory of the World,” tying AI to drug discovery and safer, privacy-protecting healthcare adoption. Public Health & Prevention: CDC reported nearly 16,000 confirmed cyclosporiasis cases across the U.S., with additional suspected cases under investigation. Mental Health Access: Iceland rolled out a national self-referral digital anxiety service for children aged 5–12, aiming to reduce referral barriers and speed up care. Data & Fraud: Lawmakers renewed focus on healthcare fraud-fighting as costs rise, spotlighting Medicare managed care, prescription drugs, and unnecessary care. Digital Health Oversight: Reports say the FTC is investigating Epic’s data access practices and related employment restrictions, as the EHR company expands AI tools.

Maternal Health & Support: National Breastfeeding Month coverage spotlights why breastfeeding plans often need flexibility, with lactation experts urging parents to avoid social-media comparisons and seek help early when latching or early exhaustion derails progress. AI in Care: A guest opinion and multiple reports highlight how AI is reshaping healthcare now—promising more personalized care and workflow gains, but also raising concerns about real-world performance (including a study where an AI-assisted stethoscope missed key findings in pets). Fraud & Compliance: DOJ and HHS OIG are prioritizing wound care fraud enforcement in 2026, targeting improper billing for skin substitutes and other wound-related services. FDA Diagnostics: The FDA cleared C2N Diagnostics’ PrecivityAD2 Alzheimer blood test for adults 40+ with cognitive symptoms, adding another blood-based amyloid option. Public Health Emergencies: Ebola in DR Congo reached 2,500 deaths, with UN leaders warning funds will run out soon and calling for urgent support to protect communities and healthcare workers. Care Access & Systems: A Ministry circular urges local authorities to ensure free medicines and supplies reach health institutions. Clinical Practice Updates: A rectal cancer trial found low vs high inferior mesenteric artery ligation had similar leakage and long-term function, with lower short-term morbidity in the low-ligation group.

Medicare Ambulance Fix: A bipartisan RESCUE Act would update Medicare ambulance fee schedules every three years to better match provider costs, after long-running reimbursement shortfalls. Drug Approvals: Zydus Lifesciences won USFDA final approval for a generic ascorbic acid injection for scurvy, expanding access to an injectable option. Cancer Screening Impact: A long-term study from Sweden’s colorectal screening program links both invitation and actual participation to lower colorectal cancer death risk. Infectious Disease Watch: Delhi is seeing an H1N1 surge, prompting a federal-state review of testing, hospital readiness, and containment steps; meanwhile, the UK warns about serious salmonella symptoms after an imported-egg-linked outbreak. Health Tech & Security: NHS data firms Arcturis and Akrivia agreed a £140m merger to scale real-world patient data services, while US/Canada agencies issued a cyber alert on active attacks targeting Siemens PLCs used in healthcare infrastructure. AI Drug Discovery: SandboxAQ rolled out AQPotency, an AI model for faster early-stage molecule-target strength predictions. Medical Manufacturing Push: India’s devices regulator push is shifting toward more local component manufacturing and value addition, not just assembly.

FDA & Rare Disease: Ultragenyx’s Genglycos (pariglasgene brecaparvovec-opnr) wins accelerated approval for glycogen storage disease type Ia, offering a one-time gene therapy for patients facing relentless raw cornstarch regimens and hypoglycemia risk. FDA & Oncology: Xspray Pharma gets a new CRL for amorphous dasatinib (Dasynoc) tied to GMP issues at a third-party manufacturer and requests for additional consecutive batch data, while clinical questions were not raised. Cancer Research: Dana-Farber’s Susana Campos discusses why IO rechallenge timing isn’t settled in gynecologic cancers and highlights resistance mechanisms like B2M and JAK1/2. Personalized Medicine: A look at individualized mRNA cancer vaccines explains how tumor sequencing selects neoantigens to train immune memory. Public Health: CDC director Erica Schwartz sets priorities on transparency, faster threat detection, and stronger state partnerships. Devices & Access: FDA authorizes Aletta, a robotic outpatient blood-draw device designed to ease phlebotomist shortages under trained supervision. Care Delivery & Workflow: A pharmacy RCM guide targets claim denials by tightening front-end billing processes. Ebola Watch: DRC Ebola cases and deaths keep rising despite Uganda declaring its outbreak over. Cardio Prevention: AHA’s Lp(a) education push spotlights low screening rates despite guideline recommendations. Health Policy: A debate over drug pricing claims challenges whether CPI-Rx trends truly reflect policy impact.

FDA Leadership Shake-Up: President Trump has picked Dr. Heidi Overton to lead the FDA, setting up a new fight over faster approvals, drug pricing, and public health priorities. Cancer Vaccine Momentum: Moderna and Merck’s personalized mRNA melanoma vaccine (with Keytruda) hit key trial goals, sending Moderna shares sharply higher and raising hopes for lower recurrence risk. Radiology & AI Debate: Mark Cuban pushed back on claims AI will replace radiologists, arguing models need domain expertise and that clinicians will still be essential. Prior Authorization Pressure: A DrFirst executive revisits insurer prior-auth pledges and warns that upcoming federal requirements may still break down unless workflows truly change. Clinical Trials Reform (UK): UK regulators report improved recruitment and faster trial setup after MHRA/HRA changes aimed at cutting delays while keeping safety standards. Healthcare Access (Kenya): Banks are financing MRI, dialysis, and oncology equipment purchases as private providers expand advanced diagnostics. Public Health & Prevention: World Mosquito Day spotlights prevention and early diagnosis for dengue, malaria, and chikungunya during monsoon season. HIV Care Expansion (Sarawak): Community-based HIV services are expanding beyond Kuching to Miri and Bintulu to bring treatment and support closer to patients. Pediatric Care Gap (India): Experts flag a shortage of pediatric super-specialists and weak coordination as major barriers to specialized care.

FDA Leadership Shake-Up: President Trump has nominated Dr. Heidi Overton, a White House policy aide, to lead the FDA, as the agency continues to operate without a permanent commissioner after recent leadership turbulence. Cancer Vaccine Breakthrough: Moderna and Merck reported a Phase 3 win for an individualized melanoma vaccine, saying it significantly delayed recurrence and spread versus Keytruda alone. Patient Safety Probe: Tennessee’s TBI is investigating a drug mix-up at a Nashville hospital that families say led to catastrophic complications in at least four patients. Health Tech & AI in Care: Oracle Health rolled out expanded AI agent features for clinical documentation, fee coding, and chart review, while regulators and clinicians continue debating how AI should be governed in medicine. Access & Outcomes: A study in JAMA Network Open links Medicaid expansion with better NSCLC coverage, earlier diagnosis, and improved survival. Digital Health Safety: The UK’s HSSIB flagged risks in NHS “Advice and Guidance” workflows, urging faster evaluation and better physician job planning. MedTech Partnership: Cleveland Clinic and Siemens Healthineers signed a new 10-year imaging and oncology partnership to upgrade care and training. Pharma Supply Chain & Manufacturing: Nigeria’s Emzor raised N26.7bn via bonds to expand drug production, including work on local antimalarial API manufacturing. E-Pharmacy Expansion: Pakistan’s Daraz launched a licensed e-pharmacy with OTC medicines delivered in 1–3 days. UTI Mechanism Insight: New research points to previously overlooked bladder nerves that may help reduce UTI burden by triggering pain and urgency responses.

Phase 3 Melanoma Breakthrough: Merck and Moderna reported positive Phase 3 INTerpath-001 results for intismeran autogene plus KEYTRUDA in completely resected stage IIB-IV melanoma, hitting recurrence-free and distant metastasis-free survival endpoints and marking a first for an individualized neoantigen mRNA therapy reaching Phase 3. Rare Disease Gene Therapy Move: Atsena Therapeutics added Matt Pauls to its board as it pushes late-stage ocular gene therapy programs toward pivotal trials and future commercialization. AI in Drug Discovery Debate: A startup, Vivodyne, argues today’s AI drug discovery is held back by a lack of causal human-tissue data, pitching robotic lab systems that grow tissue and run autonomous dosing/monitoring. Pharma Supply Chain & Quality: IAG Cargo expanded its Constant Climate cold-chain network with a new Kuala Lumpur station, while ENCLONY highlighted automated vision inspection plus integrated laser printing for tablet/capsule quality control. Healthcare Access Pressure: Reuters reports U.S. families and providers are under strain after the Trump crackdown ending Haitian TPS, removing caregivers and nursing assistants from the workforce. Clinical Tech in Stroke: A clinician profile explains how UMC New Orleans adopted the FDA-cleared THUNDERBOLT computer-assisted vacuum thrombectomy platform. Policy Watch: The UK’s CMA opened investigations into drip pricing practices involving Trainline, Virgin Atlantic, and Red Driving School.

Ambient AI in clinical workflows: Penn Medicine says its ambient documentation tools are cutting charting time by about 20% and reducing after-hours documentation for most users, while also flagging a possible rise in orders that teams are now investigating. Aging-focused care redesign: The AHA highlights how hospitals are modernizing for older adults through workforce training, tech use, and models like telehealth and hospital-at-home. Behavioral health funding: HHS is awarding $96.7M in grants for suicide prevention, serious mental illness supports, substance use disorder treatment, and disaster emotional support. Immunization warning: CDC reports kindergarten vaccine exemptions jumped to 4.2% (from 3.6%), with coverage declines across multiple vaccines. Medicare quality push: CMS launches QualTech to back innovative tech—especially AI—for better outcomes, wellness visits, and quality measurement. Biopharma manufacturing expansion: WuXi XDC secured GMP release for a Singapore dual-function production line to boost antibody intermediate and conjugated drug substance capacity. Drug trade risk: UN experts warn lab equipment can be diverted via secondary markets into illicit drug production. Prior auth automation deal: R1 plans to acquire Humata Health to streamline agentic AI prior authorizations across payers. COVID uptick: CDC says cases are rising in all 50 states, with growth fastest in the South and West. Health equity gap: A study finds men with disabilities are less likely to get PSA screening.

AI in Pharma Data: ACMA says next-gen healthcare AI needs more than knowledge access—its Medical Affairs data plus compliance-ready expertise could be the “critical intelligence layer.” Psychiatric Safety: A case report links non-prescription medicinal mushroom supplements to a sudden psychosis relapse, underscoring the need to disclose supplements to clinicians. Oncology Radiotherapy: JAMA reports SBRT improved bowel quality of life and reduced some urinary side effects versus moderately hypofractionated IMRT in favorable intermediate-risk prostate cancer, though it didn’t beat IMRT on disease-free survival. Hospital Expansion (India): Manipal Health will add 100 beds in Bengaluru via a ₹130 crore acquisition of Kinder Women’s Hospital. Public Hospital Accountability (India): Kerala orders all govt hospitals to display doctors’ names and OP timings to curb missed duty. Medical Corruption Case (India): A Delhi court rejected bail for a Central Procurement Agency official in a major medical procurement scam. Infectious Disease: UKHSA reports a salmonella outbreak possibly linked to imported eggs, with one death and hundreds of cases. Transplant Policy (South Korea): Transplant clinicians call for linking end-of-life treatment decisions with transplant law to boost donation.

Cancer Care Evidence: A Mount Sinai retrospective in JAMA Otolaryngology found neoadjuvant chemoimmunotherapy (NACI) drove far higher deep pathologic response in resectable HNSCC than immunotherapy alone (67% vs 3.6%), with especially strong results in HPV-associated disease. FDA & Cardiovascular: LIB Therapeutics’ Lerochol got FDA approval for a self-administered autoinjector and an updated label showing LDL lowering with PCSK9 inhibitor add-on to statins reduces major cardiovascular events. FDA & Cell Therapy: AbelZeta Pharma’s prizlon-cel CAR T therapy won FDA IND clearance for relapsed/refractory large B-cell lymphoma, using a CD20/CD19 bispecific design aimed at reducing antigen-negative relapse. Drug Pricing Pressure: A survey says nearly half of Medicare Part D beneficiaries feel they’re paying more for price-negotiated drugs, with many also reporting access friction like prior authorization. Healthcare Access on the Ground: CalOptima’s street medicine program is expanding to four more Orange County cities to bring primary and behavioral care to people experiencing homelessness. Digital Health Pilot: The FDA selected Cadence for the TEMPO digital health pilot to generate real-world outcomes data for its AI hypertension management software. Workforce & Care Delivery: A VA OIG investigation tied a 2025 work-from-home mandate to a radiologist “mass exodus,” contributing to MRI and CT backlogs that were later addressed.

Cancer Care Update: The TOPAZ-1 panel revisits the phase 3 design of durvalumab plus gemcitabine/cisplatin for unresectable or metastatic biliary tract cancer, highlighting a sustained overall survival edge and the ongoing challenge of pinpointing which patients get durable benefit. Mental Health in Oncology: A practical oncology depression treatment framework walks through ruling out delirium, bipolar disorder, medical causes, and neurocognitive issues, then matching PHQ-9 severity and symptoms to a simple medication toolkit plus psychotherapy and lifestyle steps. Drug Pricing & Access: California’s CalRx generic insulin label is finally showing up in retail, with Walgreens stocking $55 insulin glargine pens—an early test of whether state-led pricing can pressure big insulin makers. Climate & Health Costs: New managed-care analysis links extreme heat days to higher emergency visits and costs, underscoring the need for proactive heat planning for vulnerable members. Real-World Biologics: Clinicians discuss how biologics are increasingly used earlier in psoriatic arthritis, including payer access workarounds. Health Insurance Leadership: Centene says CFO Drew Asher will step down, signaling continued turbulence in government-backed coverage. Regulatory Scrutiny in Gene Therapy: Reports of undisclosed deaths in China’s investigator-led gene therapy pathway raise questions about oversight and transparency. Medical Workforce Oversight: India’s NMC proposes syncing doctors’ disciplinary actions into a national register to track license status across states.

Aged Care Access & AI: A new report argues nurses in aged care lose time to paperwork because clinical guidance is hard to find “in the moment,” and points to generative AI that answers staff questions using approved internal sources to free up more bedside care. Women’s Health Funding & Reimbursement: The Milken Institute flags coverage and reimbursement as a major barrier for women’s health startups, warning that companies often plan products without mapping payment pathways early. Cancer Care Regulatory Update: The FDA’s priority review for subcutaneous amivantamab plus hyaluronidase in recurrent/metastatic head and neck squamous cell carcinoma highlights a dual EGFR/MET approach and how eligibility and response rates may shape post–checkpoint and chemo options. Vaccines in Action: Afghanistan’s Nangarhar polio campaign targets nearly 1 million children, using a mix of injectable and oral doses across districts. Biotech IPO Watch: Vogenx’s $81M IPO brings a metabolic drug candidate for post-bariatric hypoglycemia into public markets as it seeks a first-in-class path for a condition with no FDA-approved therapies. Blood Supply Crisis: The American Red Cross declares a national type O blood supply crisis, warning hospitals may need to postpone elective surgeries. Workforce Pressure: A separate piece notes healthcare organizations are still wrestling with staffing shortages that affect access, staff well-being, and patient outcomes. Antibiotic Resistance Case: A clinical case describes daptomycin-resistant VREfm after transplant-related infection, underscoring rising treatment challenges in high-risk patients.

Pharma Ambition Push: PM Modi used India’s Independence Day to urge Indian pharma firms to become global top-five players, aiming for stronger worldwide brands and competitiveness. AI for Clinicians: A new report says AI could reduce doctors’ paperwork and admin load as a looming global health worker shortage strains care delivery. Cardiac Triage Standardization: PGI is asking India’s health ministry to adopt its dedicated cardiac emergency triage model after reporting a 0.5% mortality rate in 3,049 patients, with rapid escalation to CCU. Vaccine Policy Backlash: A commentary warns Trump’s proposed childhood vaccine schedule changes could undermine measles protection and leave parents in a bind. Local Drug Production Drive: Nigeria’s pharma manufacturers urged stronger API policy and industrial power tariffs to cut costs and boost local medicine output. Patient Safety Spotlight: UK researchers are evaluating “Martha’s Rule” to help patients and families raise concerns when someone’s condition deteriorates. Public Health Alerts: Japan encephalitis cases rose in Nepal’s Jhapa during monsoon season, with deaths reported and mosquito-control urged. Wellness Trend With Research: More women are trying cold plunges as studies explore potential benefits for recovery and mood.